Search results for "Cirrhosis"
HCV drug approved as 8-week regimen
The combination drug is indicated to treat all treatment-naive adults and some children who have chronic hepatitis C virus (HCV) genotypes 1 through 6 infection, either without cirrhosis or with compensated cirrhosis.
https://gastroenterology.acponline.org/archives/2019/10/25/7.htm
25 Oct 2019
Spotlight on hepatitis A, B, and C
The past month's gastroenterology research may not have been simple as ABC, but it did focus on the major types of hepatitis, including a hepatitis A outbreak, a comparison of hepatitis B drugs, and new data on hepatitis C complications and incidence.
https://gastroenterology.acponline.org/archives/2019/10/25/5.htm
25 Oct 2019
MKSAP Quiz: Management of hepatic encephalopathy
This month's quiz asks readers to determine the most appropriate course of management for a 56-year-old man presenting with altered mental status and a history of cirrhosis and anxiety.
https://gastroenterology.acponline.org/archives/2019/11/22/4.htm
22 Nov 2019
C. diff-related bloodstream infection seen less often with FMT vs. antibiotics
While fecal microbiota transplantation (FMT) was associated with fewer bloodstream infections than antibiotics in one study, a brief report described two cases of drug-resistant bacteremia transmitted by FMT.
https://gastroenterology.acponline.org/archives/2019/11/22/9.htm
22 Nov 2019
MKSAP Quiz: Follow-up evaluation after HCV treatment
This month's quiz asks readers to determine the most appropriate course of management for a 62-year-old woman with hepatitis C virus (HCV) infection and well-compensated cirrhosis.
https://gastroenterology.acponline.org/archives/2019/12/27/4.htm
27 Dec 2019
More concentrated care linked to adverse outcomes in patients with cirrhosis
A retrospective cohort study looked at patients with cirrhosis who were enrolled in Medicare and had had more than four outpatient visits over 180 days.
https://gastroenterology.acponline.org/archives/2020/01/24/2.htm
24 Jan 2020
Guideline offers recommendations on anticoagulation, thromboses in vascular liver disorders
Among other guidance, the American College of Gastroenterology recommends anticoagulation for all patients without cirrhosis who have acute symptomatic portal vein thrombosis or mesenteric vein thrombosis in the absence of any contraindication.
https://gastroenterology.acponline.org/archives/2020/01/24/1.htm
24 Jan 2020
Score predicts hepatic decompensation among patients with NAFLD
Age, presence of diabetes, and platelet count were significant predictors of hepatic events up to 12 years from the time of nonalcoholic fatty liver disease (NAFLD) diagnosis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2020/03/27/1.htm
27 Mar 2020
Risk and severity of NAFLD differ in men and women
Women have a significantly lower risk of developing nonalcoholic fatty liver disease (NAFLD) but a higher risk of developing advanced fibrosis from NAFLD, according to a systematic review and meta-analysis.
https://gastroenterology.acponline.org/archives/2020/05/22/3.htm
22 May 2020
Spotlight on HBV infection
In the past month, the U.S. Preventive Services Task Force published a draft recommendation statement on screening for hepatitis B virus (HBV) infection, and two systematic reviews and meta-analyses looked at treatments and a novel immunoassay to quantify HBV DNA.
https://gastroenterology.acponline.org/archives/2020/05/22/5.htm
22 May 2020